Pharma, Consumer Advocates Clash Over FDA-USPTO Collab

By Dani Kass (February 16, 2023, 10:26 PM EST) — Major pharmaceutical organizations are urging the U.S. Patent and Trademark Office and U.S. Food and Drug Administration not to work closer on patent work, arguing the current system works well to prevent abuse, a claim patient advocacy organizations have disputed….